Neogen Corporation

Neogen Corporation

NEOG
Neogen CorporationUS flagNASDAQ Global Select
11.75
USD
-0.14
- -
2.56BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.53
2.86
3.21
3.52
3.85
3.97
3.96
4.36
4.89
3.8
4.27
4.12
4
4
Basic EPS, GAAP
0.29
0.34
0.36
0.43
0.61
0.58
0.56
0.57
0.45
-0.11
-0.04
-5.03
-0.04
-0.04
Free Cash Flow per Basic Share
0.1
0.35
0.21
0.45
0.47
0.47
0.58
0.51
0.4
-0.11
-0.35
-0.21
0.15
0.15
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
3.13
3.54
4.03
4.63
5.41
6.11
6.85
7.82
8.23
14.49
14.51
9.54
9.61
9.61
Tangible Book Value per Share
1.96
2.37
2.57
2.92
3.78
4.47
5.18
5.74
5.91
-2.81
-2.32
-1.86
-1.25
-1.25
Basic Weighted Avg Shares
98
99
100
102
103
104
106
107
108
216
217
217
218
218
Sales/Revenue/Turnover
247
283
321
358
398
414
418
468
527
822
924
895
870
870
Operating Margin (%)
17.54
18.76
17.55
18.13
17.64
16.44
16.15
15.83
11.12
4.56
6.34
-0.19
-2.48
-2.49
Depreciation Expense
9
11
12
15
17
18
18
21
24
90
121
126
122
122
Net Income, GAAP
28
34
37
44
63
60
59
61
48
-23
-9
-1,092
-8
-8
Effective Tax Rate (%)
34.86
35.53
34.18
34.05
13.95
17.52
17.74
19.11
19.77
- -
- -
- -
- -
17.05
Profit Margin (%)
11.38
11.84
11.38
12.22
15.87
14.53
14.22
13
9.16
-2.78
-1.02
-122.05
-0.91
-0.91
Working Capital
164
206
220
257
337
411
489
538
549
440
435
403
446
446
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
885
888
875
794
794
Total Equity
306
351
404
472
560
638
725
840
887
3,134
3,144
2,071
2,093
2,093
Return on Invested Capital (%)
10.03
10.4
9.83
9.81
11.73
9.4
8.16
7.66
5.44
- -
- -
- -
- -
- -
Return on Capital (%)
10.02
10.19
9.69
9.96
12.22
10.05
8.73
7.79
5.6
- -
- -
- -
- -
-15.54
Return on Common Equity (%)
9.97
10.2
9.68
10
12.24
10.05
8.73
7.78
5.59
-1.14
-0.3
-41.88
-0.38
-0.38

Capital Structure

FRC

in mil. unless spec.
Nov'26
Feb'26
May'26
ST Debt
- -
- -
- -
LT Borrowings
793
793
794
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
218
218
218
Market Capitalization
1,301
2,444
1,953

Working Capital

FRC

in mil. unless spec.
Nov'26
Feb'26
May'26
Total Current Assets
575
590
605
Cash, Cash Equivalents & STI
145
160
186
Accounts Receivable, Net
132
137
147
Inventories
163
162
144
Total Current Liabilities
147
151
158
Payables & Accruals
83
89
97
ST Debt
- -
- -
- -
Deferred Revenue
4
4
4

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
30.49%
45.21%
1.05%
Free Cash Flow
-3.89%
-35.31%
-168.75%
Net Income, GAAP
1,125.13%
2,238.17%
-99.28%
Sales/Revenue/Turnover
11.47%
15%
-2.72%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
229
230
229
237
924
2025
217
231
221
225
895
2026
209
225
211
225
870

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
-0.02
-0.01
-0.02
-0.04
2025
-0.06
-2.1
-0.05
-2.82
-5.03
2026
0.17
-0.07
-0.08
-0.05
-0.04

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Mikhael Nassif
Full Time Employees
2,636
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Address
620 Lesher Place Lansing MI United States of America 48912-1595
IPO Date
Aug 23, 1989
Website
neogen.com
Business
Neogen Corporation (Nasdaq: NEOG), founded in 1982 and headquartered in Lansing, Michigan, develops, manufactures and markets comprehensive solutions for food and animal safety worldwide. The company operates through two primary segments: Food Safety, which offers diagnostic test kits including Reveal for Salmonella Enteritidis, Agri-Screen and Veratox for mycotoxins, NEO-GRID disposable filters, Molecular Detection Assay - Listeria Right Now for rapid Listeria species detection in environmental samples, and products to detect pathogens, toxins, allergens and contaminants in human and animal food; and Animal Safety, which provides veterinary pharmaceuticals, instruments, vaccines, topicals, rodenticides, cleaners, disinfectants, insecticides, genomics testing services for gene isolation, heredity mapping and breeding programs, and over 100 drug detection test kits for approximately 300 abused and therapeutic drugs in farm and racing animals. Neogen serves food manufacturers, processors, regulatory agencies, livestock producers, veterinarians, animal health companies, breeders, agricultural researchers and industries including agriculture and food production across more than 140 countries, with key operations in the United States, Canada, United Kingdom, Europe, Mexico, Brazil, India, China, Australia, Scotland and additional facilities in Kentucky, Wisconsin and Nebraska. In recent developments, Neogen completed the divestiture of its global cleaners and disinfectants business to Kersia Group in July 2025 for $130 million in cash plus contingent consideration, using net proceeds including $100 million to reduce debt and enhance focus on core diagnostics; appointed Mike Nassif as president and chief executive officer effective August 11, 2025, succeeding John Adent, alongside Bryan Riggsbee as chief financial officer in November 2025 and Avi Pelossof to the board in October 2025; formed a strategic partnership with Biomatter to develop AI-enabled enzyme-based products for food safety testing; renewed sponsorship with the United States Equestrian Federation in 2025 to advance equine botulism prevention education tied to its BotVax B vaccine; launched the Listeria Right Now molecular assay in 2025; and reaffirmed fiscal 2026 guidance of $820 million to $840 million in revenue and $165 million to $175 million in adjusted EBITDA following first-quarter results and restructuring with headcount reductions. The company resulted from the 2022 merger with 3M's food safety business, expanding its diagnostics portfolio and global presence.

Company News

APIChatGPT
  • Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock

  • PRGO vs. NEOG: Which Stock Is the Better Value Option?

  • Arrowstreet Capital Limited Partnership Buys New Position in Neogen Corporation $NEOG

  • Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript

  • Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates

  • Neogen Q4 Earnings Call Highlights

  • Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

  • Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

  • American Capital Management Inc. Trims Stock Position in Neogen Corporation $NEOG

  • Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026

  • Neogen Gains 101.1% in a Year: What's Driving the Rally?

  • Is it Worth Retaining NEOG Stock in Your Portfolio for Now?

  • Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm

  • Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm

  • Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification

  • NEOG Q3 Earnings & Revenues Top, Gross Margin Down, Stock Crashes

  • Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results

  • Neogen Corporation (NEOG) Q3 2026 Earnings Call Transcript

  • Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates